INM logo

InMed Pharmaceuticals (INM) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$6.57 M
-$2.34 M-26.27%

June 30, 2024


Summary


Performance

INM Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINMbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$3.42 M
-$2.16 M-38.75%

December 31, 2024


Summary


Performance

INM Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINMbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

INM Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-26.3%-55.0%
3 y3 years-10.8%-55.0%
5 y5 years-33.0%-55.0%

INM Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-26.3%+6.4%-70.1%at low
5 y5-year-33.0%+13.2%-77.7%at low
alltimeall time-64.2%-100.0%-81.4%-100.0%

InMed Pharmaceuticals Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
-
$3.42 M(-38.8%)
Sep 2024
-
$5.58 M(-15.0%)
Jun 2024
$6.57 M(-26.3%)
$6.57 M(-13.5%)
Mar 2024
-
$7.60 M(-20.3%)
Dec 2023
-
$9.53 M(+41.5%)
Sep 2023
-
$6.74 M(-24.4%)
Jun 2023
$8.91 M(+44.3%)
$8.91 M(-7.2%)
Mar 2023
-
$9.60 M(-16.1%)
Dec 2022
-
$11.45 M(+22.5%)
Sep 2022
-
$9.35 M(+51.4%)
Jun 2022
$6.18 M(-16.1%)
$6.18 M(+4.7%)
Mar 2022
-
$5.90 M(-47.7%)
Dec 2021
-
$11.28 M(-26.5%)
Sep 2021
-
$15.34 M(+108.4%)
Jun 2021
$7.36 M(+26.8%)
$7.36 M(-22.1%)
Mar 2021
-
$9.45 M(-5.7%)
Dec 2020
-
$10.02 M(+122.8%)
Sep 2020
-
$4.50 M(-22.5%)
Jun 2020
$5.81 M(-40.8%)
$5.81 M(-16.7%)
Mar 2020
-
$6.97 M(-23.8%)
Dec 2019
-
$9.15 M(-17.7%)
Sep 2019
-
$11.11 M(+13.3%)
Jun 2019
$9.81 M(-46.6%)
$9.81 M(+1.3%)
Mar 2019
-
$9.68 M(-15.0%)
Dec 2018
-
$11.40 M(-15.3%)
Sep 2018
-
$13.46 M(-26.6%)
Jun 2018
$18.35 M(+255.8%)
$18.35 M(+105.2%)
Mar 2018
-
$8.94 M(-13.3%)
Dec 2017
-
$10.31 M(+112.1%)
Sep 2017
-
$4.86 M(-5.7%)
Jun 2017
$5.16 M(>+9900.0%)
$5.16 M(+151.7%)
Mar 2017
-
$2.05 M(+288.5%)
Dec 2016
-
$527.40 K(+313.3%)
Sep 2016
-
$127.60 K(+204.5%)
Jun 2016
$41.90 K(-68.8%)
$41.90 K(+451.3%)
Mar 2016
-
$7600.00(-75.6%)
Dec 2015
-
$31.10 K(+658.5%)
Sep 2015
-
$4100.00(-96.9%)
Jun 2015
$134.20 K(+1790.1%)
$134.20 K(+232.2%)
Mar 2015
-
$40.40 K(+37.4%)
Dec 2014
-
$29.40 K(+263.0%)
Sep 2014
-
$8100.00(+14.1%)
Jun 2014
$7100.00
$7100.00(+446.2%)
DateAnnualQuarterly
Mar 2014
-
$1300.00(+44.4%)
Dec 2013
-
$900.00(-35.7%)
Sep 2013
-
$1400.00(-65.9%)
Jun 2013
$4100.00(-90.9%)
$4100.00(+86.4%)
Mar 2013
-
$2200.00(-4.3%)
Dec 2012
-
$2300.00(-87.6%)
Sep 2012
-
$18.50 K(-58.8%)
Jun 2012
$44.90 K(-80.5%)
$44.90 K(-49.7%)
Mar 2012
-
$89.30 K(-12.9%)
Dec 2011
-
$102.50 K(-41.5%)
Sep 2011
-
$175.10 K(-24.0%)
Jun 2011
$230.50 K(>+9900.0%)
$230.50 K(-61.0%)
Mar 2011
-
$591.20 K(>+9900.0%)
Jun 2010
$0.00(-100.0%)
$0.00(0.0%)
Mar 2009
-
$0.00(-100.0%)
Dec 2008
-
$2100.00(+600.0%)
Sep 2008
-
$300.00(-99.4%)
Jun 2008
$46.80 K(-63.4%)
$46.80 K(-55.7%)
Mar 2008
-
$105.70 K(-53.1%)
Dec 2007
-
$225.50 K(+47.9%)
Sep 2007
-
$152.50 K(+19.3%)
Jun 2007
$127.80 K(+170.2%)
$127.80 K(-59.5%)
Mar 2007
-
$315.50 K(+1214.6%)
Dec 2006
-
$24.00 K(+238.0%)
Sep 2006
-
$7100.00(-85.0%)
Jun 2006
$47.30 K(+228.5%)
$47.30 K(+1251.4%)
Mar 2006
-
$3500.00(-80.9%)
Dec 2005
-
$18.30 K(-29.6%)
Sep 2005
-
$26.00 K(-49.7%)
Dec 2004
-
$51.70 K(+91.5%)
Sep 2004
-
$27.00 K(+87.5%)
Jul 2004
$14.40 K(-70.7%)
$14.40 K(-48.4%)
Apr 2004
-
$27.90 K(+18.7%)
Jan 2004
-
$23.50 K(-71.1%)
Oct 2003
-
$81.30 K(+65.6%)
Jul 2003
$49.10 K(+1263.9%)
$49.10 K(+154.4%)
Apr 2003
-
$19.30 K(+26.1%)
Jan 2003
-
$15.30 K(-47.2%)
Oct 2002
-
$29.00 K(+705.6%)
Jul 2002
$3600.00(-91.2%)
$3600.00(-83.0%)
Apr 2002
-
$21.20 K(+21.1%)
Jan 2002
-
$17.50 K(+1844.4%)
Oct 2001
-
$900.00
Jul 2001
$41.00 K
-

FAQ

  • What is InMed Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is InMed Pharmaceuticals quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

What is InMed Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of INM is $6.57 M

What is the all time high annual cash & cash equivalents for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high annual cash & cash equivalents is $18.35 M

What is InMed Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, INM annual cash & cash equivalents has changed by -$2.34 M (-26.27%)

What is InMed Pharmaceuticals quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of INM is $3.42 M

What is the all time high quarterly cash and cash equivalents for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high quarterly cash and cash equivalents is $18.35 M

What is InMed Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

Over the past year, INM quarterly cash and cash equivalents has changed by -$4.18 M (-55.01%)